Evidence map›Paper›PMID 37686689›Full record

ArticleCancers2023

Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship.

Annelise A Madison, Rebecca Andridge, Anthony H Kantaras, Megan E Renna, Jeanette M Bennett, Catherine M Alfano, Stephen P Povoski, Doreen M Agnese, Maryam Lustberg, Robert Wesolowski and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. The Relation of Zonulin and Intestinal Fatty Acid-binding Protein with Cognitive Functions in Patients with Bipolar Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Mapping Cognitive Oncology: A Decade of Trends and Research Fronts.Medical sciences (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Annelise A MadisonInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-6091-6844
Rebecca AndridgeInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-9991-9647
Anthony H KantarasDepartment of Neuroscience, The Ohio State University, Columbus, OH 43210, USA.ORCID 0009-0000-0000-9513
Megan E RennaSchool of Psychology, University of Southern Mississippi, Hattiesburg, MS 39406, USA.ORCID 0000-0003-3941-4270
Jeanette M BennettDepartment of Psychological Science, University of North Carolina at Charlotte, Charlotte, NC 28213, USA.ORCID 0000-0002-8487-9774
Catherine M AlfanoNorthwell Health, New York, NY 10022, USA.ORCID 0000-0001-6488-2186
Stephen P PovoskiThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Doreen M AgneseThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Maryam LustbergCenter for Breast Cancer, Yale Cancer Center, Yale University, New Haven, CT 06519, USA.
Robert WesolowskiThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
William E CarsonThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Nicole O WilliamsThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Raquel E ReinboltThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Sagar D SardesaiThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Anne M NoonanThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Daniel G StoverThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Mathew A CherianThe Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0002-0380-2012
William B MalarkeyInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Janice K Kiecolt-GlaserInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
The Ohio State University · USInstitute for Behavioral Medicine · USNorthwell Health · USUniversity of North Carolina at Charlotte · USUniversity of Southern Mississippi · USYale Cancer Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral InfluencesR01CA186720 · NCI · OHIO STATE UNIVERSITY · PI KIECOLT-GLASER, JANICE · 2014 to 2018
$4.6M
Fatigue, Depression, and Inflammation in Cancer Survivors: A Prospective StudyR01CA131029 · NCI · OHIO STATE UNIVERSITY · PI KIECOLT-GLASER, JANICE · 2008 to 2013
$4.1M
Aerobic Capacity, Depression, & Inflammatory Responsivity in Cancer SurvivorsR01CA186251 · NCI · OHIO STATE UNIVERSITY · PI KIECOLT-GLASER, JANICE · 2015 to 2019
$3.1M
Breast Cancer Survivors: Physical Activity, Inflammation, Fatigue, and DistressR01CA126857 · NCI · OHIO STATE UNIVERSITY · PI KIECOLT-GLASER, JANICE · 2007 to 2012
$2.6M
Biobehavioral Influences on Cancer: Perspectives from PsychoneuroimmunologyK05CA172296 · NCI · OHIO STATE UNIVERSITY · PI KIECOLT-GLASER, JANICE · 2013 to 2017
$426k
NCATS NIH HHS UL1 TR001070NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002733NCI NIH HHS K05 CA172296NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA126857NCI NIH HHS R01 CA131029NCI NIH HHS R01 CA186251NCI NIH HHS R01 CA186720NCI NIH HHS R01CA186720NCRR NIH HHS UL1 RR025755
6 · The paper itself

Abstract

About one-in-three breast cancer survivors have lingering cognitive complaints and objective cognitive impairment. Chronic inflammation and intestinal permeability (i.e., leaky gut), two risk factors for cognitive decline, can also fuel depression-another vulnerability for cognitive decline. The current study tested whether depression accompanied by high levels of inflammation or intestinal permeability predicted lower subjective and objective cognitive function in breast cancer survivors. We combined data from four breast cancer survivor studies (

Indexed as

attentiondepressionexecutive functioninflammationLBPmemorymood

Identifiers

PMID37686689
PMCPMC10487080
OpenAlexW4386409782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.